University Urology Associates of New Jersey Announces Dr. Mukaram Gazi’s Designation as a UroLift® Center of Excellence

Share Article

Designation Recognizes Dr. Mukaram Gazi’s Commitment to Exemplary Care, Deep UroLift Experience

News Image
Our philosophy is patient-centered care and our goal is to help the patient achieve the best quality of life possible.

University Urology Associates of New Jersey today announced that Dr. Mukaram Gazi has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Gazi has achieved a high level of training and experience with the UroLift System and has demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia or BPH.

“The providers at UUANJ are dedicated to providing the highest level of patient care and a part of that is offering an array of treatment options for urological conditions. The UroLift System procedure is a relatively new procedure and a reasonable alternative to drug therapy or more invasive surgery but this procedure is not a one-size-fits-all treatment. Our philosophy is patient-centered care and our goal is to help the patient achieve the best quality of life possible,” said Dr. Mukaram Gazi

Nearly 40 million men in the United States are affected by BPH. Not to be confused with prostate cancer, BPH occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems, and can cause loss of productivity, depression and decreased quality of life.

Five-year data from a randomized study shows the UroLift System offers not only rapid improvement, but also durable relief for patients with BPH. After five years, patients treated with the UroLift System continue to experience symptom relief with minimal side effects, with few patients requiring an additional procedure for relief. A second randomized clinical trial called BPH6 demonstrated that the minimally invasive UroLift System compares very well to the reference standard surgery, transurethral resection of the prostate (TURP), with regard to efficacy, and is superior to TURP at preserving sexual function and offering a more rapid recovery.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation.

About the UroLift System
NeoTract’s FDA-cleared UroLift System is a novel, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at

About University Urology Associates of New Jersey
University Urology Associates of New Jersey (UUANJ) was established in 2003 and is proud to be serving Mercer, Monmouth and Ocean Counties. Our mission is to be a solution-based practice, maximizing the value of the service we deliver our patients with commitment to excellence, integrity, innovation and treatment. The Physicians at UUANJ have been recognized as “Top Doctors” by both NJ Monthly and Inside Jersey Magazine. Dr. Gazi, who leads the men’s health and wellness program at UUANJ is also recognized as a top urologist by Castle Connelly and US News and World Report.

# # #

Media Contact for the UroLift® System:
Amy Cramer
M: 650-391-3714

Media Contact for University Urology Associates of New Jersey:
Tillie Lee
(609) 581-5900

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Hill
NeoTract Inc.
+1 (925) 201-8285
Email >

Tillie Lee
University Urology Associates of New Jersey
(609) 581-5900
Email >